The intracrine sex steroid biosynthesis pathways

Progress in Brain Research

Volumn 181, Issue C, 2010, Pages 177-192

  Luu The, Van ^a   Labrie, Fernand ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Androgens; Dehydroepiandrosterone; Estrogens; Menopause; Steroidogenesis

Indexed keywords

20ALPHA HYDROXYSTEROID DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTANOLONE; AROMATASE; ESTRADIOL; ESTROGEN; GLUCURONOSYLTRANSFERASE; PRASTERONE; SEX HORMONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE; 17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 3; 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3; GONADORELIN; HYDROXYSTEROID DEHYDROGENASE; STEROID MONOOXYGENASE;

ADIPOCYTE; ARABIDOPSIS; ARTICLE; CAENORHABDITIS ELEGANS; CATALYSIS; CELL PROLIFERATION; GENE MUTATION; HUMAN; MACACA FASCICULARIS; MOLECULAR EVOLUTION; NONHUMAN; OVARY FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; STEROIDOGENESIS; TESTIS FUNCTION; ADRENAL GLAND; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CLASSIFICATION; FEMALE; GENETICS; MALE; METABOLISM; OVARY; REVIEW; TESTIS;

17-HYDROXYSTEROID DEHYDROGENASES; ADRENAL GLANDS; ANIMALS; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; ESTRADIOL; EVOLUTION, MOLECULAR; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; OVARY; STEROID HYDROXYLASES; TESTIS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 77955507711     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)81010-2     Document Type: Article

References (92)

1. Andersson, S., Berman, D. M., Jenkins, E. P., & Russell, D. W. (1991). Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature, 354(6349), 159-161.
2. Andersson, S. & Russell, D. W. (1990). Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proceedings of the National Academy of Sciences of the United States of America, 87 (10), 3640-3644.
3. Baker, M. E. (1997). Steroid receptor phylogeny and vertebrate origins. Molecular and Cellular Endocrinology, 135 (2), 101-107.
4. Baker, M. E. (2001a). Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Molecular and Cellular Endocrinology, 171 (1-2), 211-215.
5. Baker, M. E. (2001b). Hydroxysteroid dehydrogenases: Ancient and modern regulators of adrenal and sex steroid action. Molecular and Cellular Endocrinology, 175(1-2), 1-4.
6. Baker, M. E., Luu-The, Y., Simard, J., & Labrie, F. (1990). A common ancestor for mammalian 3 beta-hydroxysteroid dehydrogenase and plant dihydroflavonol reductase. The Biochemical Journal, 269(2), 558-559.
7. Belanger, A., Brochu, M., Lacoste, D., Noel, C., Labrie, F., Dupont, A., et al. (1991). Steroid glucuronides: Human circulatory levels and formation by LNCaP cells. The Journal of Steroid Biochemistry and Molecular Biology, 40(4-6), 593-598.
8. Belanger, A., Pelletier, G., Labrie, F., Barbier, O., & Chouinard, S. (2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends in Endocrinology and Metabolism, 14(10), 473-479.
9. Bellemare, V., Laberge, P., Noel, S., Tchernof, A., & Luu-The, V. (2009). Differential estrogenic 17beta-hydroxysteroid dehydrogenase activity and type 12 17beta-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes. Journal of Steroid Biochemistry and Molecular Biology, 114(3-5), 129-134.
10. Bellemare, V., Phaneuf, D., & Luu-The, V. (2009). Type 12 17beta-hydroxysteroid dehydrogenase knock-out mouse: Reduction of androgen and estrogen levels in heterozygotes and embryonic lethality in homozygotes. 13th International Congress on Hormonal Steroids and Hormones & Cancer (p.P-119). Quebec.
11. Bertrand, S., Brunet, F. G., Escriva, H., Parmentier, G., Laudet, V., & Robinson-Rechavi, M. (2004). Evolutionary genomics of nuclear receptors: From twenty-five ancestral genes to derived endocrine systems. Molecular Biology and Evolution, 21(10), 1923-1937.
12. Berube, D., Luu The, V., Lachance, Y., Gagne, R., & Labrie, F. (1989). Assignment of the human 3 beta-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of chromosome 1. Cytogenetics and Cell Genetics, 52(3-4), 199-200.
13. Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998). Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. The New England Journal of Medicine, 339(9), 599-603.
14. Blanchard, P. G. & Luu-The, V. (2007). Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase. Journal of Endocrinology, 194(2), 449-455.
15. Brock, B. J. & Waterman, M. R. (1999). Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry, 38(5), 1598-1606.
16. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., et al. (1997). Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine, 337(2), 91-95.
17. Colbert, E. H. & Morales, M. (1991). Evolution of vertebrates: A history of the backboned animals through time. New York: Wiley-Liss.
18. Desnoyers, S., Blanchard, P.-G., St-Laurent, J.-F., Gagnon, S., Baillie, D. L., & Luu-The, V. (2007). C. elegans LET-767 is able to metabolize androgens and estrogens and likely shares common ancestor with human types 3 and 12 17bhydroxysteroid dehydrogenases. Journal of Endocrinology, 195, 271-279.
19. Deyashiki, Y., Ohshima, K., Nakanishi, M., Sato, K., Matsuura, K., & Hara, A. (1995). Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase (A-specific), a member of the aldoketoreductase family. The Journal of Biological Chemistry, 270(18), 10461-10467.
20. Dufort, I., Labrie, F., & Luu-The, V. (2001). Human types 1 and 3 3alpha-hydroxysteroid dehydrogenases: Differential lability and tissue distribution. Journal of Clinical Endocrinology and Metabolism, 86(2), 841-846.
21. Dufort, I., Rheault, P., Huang, X.-F., Soucy, P., & Luu-The, V. (1999). Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology, 140(2), 568-574.
22. Dumont, M., Luu-The, V., Dupont, E., Pelletier, G., & Labrie, F. (1992b). Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/ delta 5-delta 4 isomerase in human skin. The Journal of Investigative Dermatology, 99(4), 415-421.
23. Dumont, M., Luu-The, V., de Launoit, Y., & Labrie, F. (1992a). Expression of human 17 beta-hydroxysteroid dehydrogenase in mammalian cells. The Journal of Steroid Biochemistry and Molecular Biology, 41(3-8), 605-608.
24. Entchev, E. V., Schwudke, D., Zagoriy, V., Matyash, V., Bogdanova, A., Habermann, B., et al. (2008). LET-767 is required for the production of branched chain and long chain fatty acids in Caenorhabditis elegans. The Journal of Biological Chemistry, 283(25), 17550-17560.
25. Fisher, C. R., Graves, K. H., Parlow, A. F., & Simpson, E. R. (1998). Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proceedings of the National Academy of Sciences of the United States of America, 95(12), 6965-6970.
26. Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., et al. (1994). Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nature Genetics, 7(1), 34-39.
27. Guillemette, C., Belanger, A., & Lepine, J. (2004). Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: An overview. Breast Cancer Research, 6(6), 246-254.
28. Imperato-McGinley, J., Ip, N. Y., Gautier, T., Neuweiler, J., Gruenspan, H., Liao, S., et al. (1990). DNA linkage analysis and studies of the androgen receptor gene in a large kindred with complete androgen insensitivity. American Journal of Medical Genetics, 36(1), 104-108.
29. Kellis, J. T. Jr. & Vickery, L. E. (1987). Purification and characterization of human placental aromatase cytochrome P-450. The Journal of Biological Chemistry, 262(9), 4413-4420.
30. Korach, K. S. (1994). Insights from the study of animals lacking functional estrogen receptor. Science, 266(5190), 1524-1527.
31. Krazeisen, A., Breitling, R., Imai, K., Fritz, S., Moller, G., & Adamski, J. (1999). Determination of cDNA, gene structure and chromosomal localization of the novel human 17betahydroxysteroid dehydrogenase type 7(1). FEBS Letters, 460(2), 373-379.
32. Kuervers, L. M., Jones, C. L., O'Neil, N. J., & Baillie, D. L. (2003). The sterol modifying enzyme LET-767 is essential for growth, reproduction and development in Caenorhabditis elegans. Molecular Genetics and Genomics, 270(2), 121-131.
33. Labrie, F. (1991). Intracrinology. Molecular and Cellular Endocrinology, 78(3), C113-C118.
34. Labrie, F. (2007). Drug insight: Breast cancer prevention and tissue-targeted hormone replacement therapy. Nature Clinical Practice Endocrinology and Metabolism, 3(8), 584-593.
35. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J. L., et al. (2009a). Intravaginal dehydroepiandrosterone (prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause, 16(5), 907-922.
36. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J. L., et al. (2009b). Effect of intravaginal dehydroepiandrosterone (prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause, 16(5), 923-931.
37. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J. L., et al. (2009c). Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause, 16(5), 897-906.
38. Labrie, F., Belanger, A., Belanger, P., Berube, R., Martel, C., Cusan, L., et al. (2006). Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. The Journal of Steroid Biochemistry and Molecular Biology, 99(4-5), 182-188.
39. Labrie, F., Bélanger, A., Cusan, L., Seguin, C., Pelletier, G., Kelly, P. A., et al. (1980). Antifertility effects of LHRH agonists in the male. Journal of Andrology, 1, 209-228.
40. Labrie, F., Cusan, L., Gomez, J. L., Cote, I., Berube, R., Belanger, P., et al. (2008). Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology, 111(3-5), 178-194.
41. Labrie, F., Dupont, A., & Belanger, A. (1985). Complete androgen blockade for the treatment of prostate cancer. Important Advances in Oncology, 193-217.
42. Labrie, Y., Durocher, F., Lachance, Y., Turgeon, C., Simard, J., Labrie, C., et al. (1995). The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. DNA and Cell Biology, 14(10), 849-861.
43. Labrie, F., Luu-The, V., Belanger, A., Lin, S. X., Simard, J., Pelletier, G., et al. (2005). Is dehydroepiandrosterone a hormone? Journal of Endocrinology, 187(2), 169-196.
44. Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001). DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology. Frontiers in Neuroendocrinology, 22(3), 185-212.
45. Labrie, F., Sugimoto, Y., Luu-The, V., Simard, J., Lachance, Y., Bachvarov, D., et al. (1992). Structure of human type II 5 alpha-reductase gene. Endocrinology, 131(3), 1571-1573.
46. Lachance, Y., Luu-The, V., Labrie, C., Simard, J., Dumont, M., de Launoit, Y., et al. (1990). Characterization of human 3bhydroxysteroid dehydrogenase/D5-D4 isomerase gene and its expression in mammalian cells. Journal of Biological Chemistry, 265(33), 20469-20475.
47. Lachance, Y., Luu-The, V., Verreault, H., Dumont, M., Rheaume, É., Leblanc, G., et al. (1991). Structure of the human type II 3b-hydroxysteroid dehydrogenase/D5-D4 isomerase (3b-HSD) gene: Adrenal and gonadal specificity. DNA and Cell Biology, 10(10), 701-711.
48. Laudet, V. (1997). Evolution of the nuclear receptor superfamily: Early diversification from an ancestral orphan receptor. Journal of Molecular Endocrinology, 19(3), 207-226.
49. Li, J., Biswas, M. G., Chao, A., Russell, D. W., & Chory, J. (1997). Conservation of function between mammalian and plant steroid 5alpha-reductases. Proceedings of the National Academy of Sciences of the United States of America, 94(8), 3554-3559.
50. Liu, H. (2007). Molecular cloning and characterization of enzymes involved in sex hormone formation and inactivation in cynomolgus monkey. Ph. D., Endocrinology and Physiology Program, Department of Physiology and Anatomy, Laval University, Quebec.
51. Liu, H., Bellemare, V., Labrie, F., & Luu-The, V. (2007). Molecular characterization of the cynomolgus monkey Macaca fascicularis steroidogenic enzymes belonging to the aldo-keto reductase family. The Journal of Steroid Biochemistry and Molecular Biology, 104(1-2), 75-80.
52. Liu, H., Zheng, S., Bellemare, V., Pelletier, G., Labrie, F., & Luu-The, V. (2007). Expression and localization of estrogenic type 12 17beta-hydroxysteroid dehydrogenase in the cynomolgus monkey. BMC Biochemistry, 8, 2.
53. Lorence, M. C., Corbin, C. J., Kamimura, N., Mahendroo, M. S., & Mason, J. I. (1990). Structural analysis of the gene encoding human 3 beta-hydroxysteroid dehydrogenase/ delta 5-4-isomerase. Molecular Endocrinology, 4(12), 1850-1855.
54. Luo, M., Xiao, Y., Li, X., Lu, X., Deng, W., Li, D., et al. (2007). GhDET2, a steroid 5alpha-reductase, plays an important role in cotton fiber cell initiation and elongation. The Plant Journal, 51(3), 419-430.
55. Luu The, V., Labrie, C., Zhao, H. F., Couet, J., Lachance, Y., Simard, J., et al. (1989). Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: Evidence of two mRNA species with distinct 5'-termini in human placenta. Molecular Endocrinology, 3(8), 1301-1309.
56. Luu The, V., Lachance, Y., Leblanc, G., & Labrie, F. (1992). Human 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase: Characterization of the three additional related genes. 74th Annual Meeting of the Endocrine Society, San Antonio, Texas.
57. Luu-The, V. (2001). Analysis and characteristics of multiple types of human 17b-hydroxysteroid dehydrogenases. Journal of Steroid Biochemistry and Molecular Biology, 76(1-5), 143-151.
58. Luu-The, V., Belanger, A., & Labrie, F. (2008). Androgen biosynthetic pathways in the human prostate. Best Practice and Research Clinical Endocrinology and Metabolism, 22(2), 207-221.
59. Luu-The, V., Dufort, I., Pelletier, G., & Labrie, F. (2001). Type 5 17b-hydroxysteroid dehydrogenase: Its role in the formation of androgens in women. Molecular and Cellular Endocrinology, 171(1-2), 77-82.
60. Luu-The, V., Labrie, C., Simard, J., Lachance, Y., Zhao, H.-F., Couët, J., et al. (1990a). Structure of two in tandem human 17b-hydroxysteroid dehydrogenase genes. Molecular Endocrinology, 4(2), 268-275.
61. Luu-The, V., Labrie, C., Zhao, H. F., Couet, J., Lachance, Y., Simard, J., et al. (1990b). Purification, cloning, complementary DNA structure, and predicted amino acid sequence of human estradiol 17 beta-dehydrogenase. Annals of the New York Academy of Sciences, 595, 40-52.
62. Luu-The, V., Lachance, Y., Labrie, C., Leblanc, G., Thomas, J. L., Strickler, R. C., et al. (1989). Full length cDNA structure and deduced amino acid sequence of human 3bhydroxy-5-ene steroid dehydrogenase. Molecular Endocrinology, 3(8), 1310-1312.
63. Luu-The, V., Pelletier, G., & Labrie, F. (2005). Quantitative appreciation of steroidogenic gene expression in mouse tissues: New roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase. The Journal of Steroid Biochemistry and Molecular Biology, 93 (2-5), 269-276.
64. Luu-The, V., Tremblay, P., & Labrie, F. (2006). Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Molecular Endocrinology, 20(2), 437-443.
65. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenetics and Genomics, 15(10), 677-685.
66. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., et al. (1997). The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics, 7(4), 255-269.
67. McBride, M. W., McVie, A. J., Burridge, S. M., Brintnell, B., Craig, N., Wallace, A. M., et al. (1999). Cloning, expression, and physical mapping of the 3beta-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human. Genomics, 61(3), 277-284.
68. Moon, Y. A. & Horton, J. D. (2003). Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. The Journal of Biological Chemistry, 278(9), 7335-7343.
69. Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995). Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism, 80(12), 3689-3698.
70. Mouridsen, H., Gershanovich, M., Sun, Y., Perez-Carrion, R., Boni, C., Monnier, A., et al. (2003). Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the international letrozole breast cancer group. Journal of Clinical Oncology, 21(11), 2101-2109.
71. Noguchi, T., Fujioka, S., Takatsuto, S., Sakurai, A., Yoshida, S., Li, J., et al. (1999). Arabidopsis det2 is defective in the conversion of (24r)-24-methylcholest-4-en-3-one to (24r)-24-methyl-5alpha-cholestan-3-one in brassinosteroid biosynthesis. Plant Physiology, 120(3), 833-840.
72. Nokelainen, P., Puranen, T., Peltoketo, H., Orava, M., Vihko, P., & Vihko,R. (1996).Molecular cloning ofmouse 17 beta-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. European Journal of Biochemistry, 236(2), 482-490.
73. Payne, A. H. & Hales, D. B. (2004). Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine Reviews, 25(6), 947-970.
74. Peltoketo, H., Isomaa, V., Maentausta, O., & Vihko, R. (1988). Complete amino acid sequence of human placental 17 betahydroxysteroid dehydrogenase deduced from cDNA. FEBS Letters, 239(1), 73-77.
75. Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Sturla, E. (1977). Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency. American Journal of Medicine, 62(2), 170-191.
76. Reed, K. C. & Ohno, S. (1976). Kinetic properties of human placental aromatase. Application of an assay measuring 3H2O release from 1beta,2beta-3h-androgens. The Journal of Biological Chemistry, 251(6), 1625-1631.
77. Rheaume,É.,Lachance,Y.,Zhao,H.-F.,Breton,N.,Dumont,M., de Launoit, Y., et al. (1991). Structure and expression of a new complementary DNA encoding the almost exclusive 3b-hydroxysteroid dehydrogenase/D5-D4-isomerase in human adrenals and gonads. Molecular Endocrinology, 5(8), 1147-1157.
78. Rheaume, E., Simard, J.,Morel, Y., Mebarki, F., Zachmann, M., Forest, M. G., et al. (1992). Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nature Genetics, 1(4), 239-245.
79. Russell, A. J., Wallace, A. M., Forest, M. G., Donaldson, M. D., Edwards, C. R., & Sutcliffe, R. G. (1994). Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. Journal of Molecular Endocrinology, 12(2), 225-237.
80. Russell, D. W. & Wilson, J. D. (1994). Steroid 5 alpha-reductase: Two genes/two enzymes. Annual Review of Biochemistry, 63, 25-61.
81. Samson, M., Labrie, F., & Luu-The, V. (2009a). Sequential transformation of 4-androstenedione into dihydrotestosterone in prostate carcinoma (DU-145) cells indicates that 4-androstenedione and not testosterone is the substrate of 5alpha-reductase. Hormone Molecular Biology Clinical Investigation, 1, 63-72.
82. Samson, M., Labrie, F., & Luu-The, V. (2009b). Specific estradiol biosynthetic pathway in choriocarcinoma (JEG-3) cell line. The Journal of Steroid Biochemistry and Molecular Biology, 116(3-5), 154-159.
83. Samson, M., Labrie, F., Zouboulis, C. C., & Luu-The, V. (2009c). Biosynthesis of dihydrotestosterone by a pathway that does not require testosterone as intermediate in the SZ95 sebaceous gland cell line. Journal of Investigative Dermatology, 130(2), 602-604.
84. Simard, J., Ricketts, M. L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005). Molecular biology of the 3betahydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocrine Reviews, 26(4), 525-582.
85. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., et al. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews, 15(3), 342-355.
86. Simpson, E. R., Michael, M. D., Agarwal, V. R., Hinshelwood, M. M., Bulun, S. E., & Zhao, Y. (1997). Cytochromes P450 11: Expression of the CYP19 (aromatase) gene: An unusual case of alternative promoter usage. The FASEB Journal, 11 (1), 29-36.
87. Sugimoto, Y., Lopez-Solache, I., Labrie, F., & Luu-The, V. (1995). Cations inhibit specifically type I 5 alpha-reductase found in human skin. The Journal of Investigative Dermatology, 104(5), 775-778.
88. Uemura, M., Tamura, K., Chung, S., Honma, S., Okuyama, A., Nakamura, Y., et al. (2008). Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Science, 99(1), 81-86.
89. Wilson, J. D. (1978). Sexual differentiation. Annual Review of Physiology, 40, 279-306.
90. Wu, L., Einstein, M., Geissler, W. M., Chan, H. K., Elliston, K. O., & Andersson, S. (1993). Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alphahydroxysteroid dehydrogenase activity. The Journal of Biological Chemistry, 268(17), 12964-12969.
91. Xu, W., Robert, C., Thornton, P. S., & Spinner, N. B. (2003). Complete androgen insensitivity syndrome due to X chromosome inversion: A clinical report. American Journal of Medical Genetics Part A, 120(3), 434-436.
92. Yamana, K., Labrie, F., & Luu-The, V. (2009). Characterization of a new type 3 5alpha-reductase, an enzyme involves in the biosynthesis of dihydrotestosterone, highly expressed in skin, mammary glands, breast cancer cell lines and adipose tissue, and inhibited by Finasteride. Endocrine Society Meeting. 91th Annual Meeting (p. P2-P4), Washington, DC, U.S.A.